IP Library Granted Patent US 11,452,760
Granted Patent B2
US 11,452,760 · App. 16/151,398 · Granted Sep 27, 2022

Systems and methods for improved delivery of osteoinductive molecules in bone repair

Inventors: Eric Vanderploeg (Stoneham, MA); Howard Seeherman (Cambridge, MA); Christopher G. Wilson (Auburndale, MA); John Wozney (Hudson, MA); Christopher T. Brown (Chelmsford, MA); John A. Kambouris (Durham, NC)
Assignee: BIOVENTUS, LLC
A61K38/17A61K33/06A61K38/1875A61L24/0015A61L24/0036A61L24/0084A61L24/02A61L27/12A61L27/446A61L27/54A61L27/56A61L2300/414A61L2430/02A61L2430/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,452,760
App. No.
16/151,398
Granted
Sep 27, 2022
Kind
B2
Abstract

Systems and methods for preparing synthetic osteoinductive bone grafts are provided in which a porous ceramic granule, which may be incorporated within a biocompatible matrix material, is loaded with an osteoinductive agent. Loading of granules is facilitated in some cases by the use of low-pH buffers and pre-treatments.

Claims (21)

1. A kit for use in forming an implant, the kit comprising:

a first composition including an acid etched calcium ceramic granule having a specific surface area greater than 30 m 2 /g, a pH less than 7, and an interconnected network of micropores defining at least one surface on an interior of the granule, wherein said micropores prevent multinucleated osteoclasts from penetrating into the interior of the granules; and

a second composition comprising a solution comprising an osteoinductive protein and a buffering agent having a pKa between 2.3 and 4.5, the solution having a pH of less than 4.0, wherein said second composition is separate from the first composition.

2. The kit of claim 1 , wherein the solution comprises:

25 mM Glutamic Acid;

2% (w/v) Glycine; and

1% (w/v) Sucrose.

3. The kit of claim 1 , wherein the buffering agent is selected from the group consisting of glycine, lactic acid, formic acid, malic acid, malonic acid, glutamic acid, aspartic acid, citric acid, tartaric acid, fumaric acid, succinic acid and combinations thereof.

4. The kit of claim 1 , further comprising an instructional material describing a method of making an osteoinductive implant comprising the step of:

contacting the first composition with the second composition comprising the solution, thereby associating the osteoinductive protein with an interior surface of the granule and forming an osteoinductive implant.

5. The kit of claim 4 , wherein the instructional material describes a method of treating a patient, comprising the step of:

contacting a bony tissue of the patient with the osteoinductive implant.

6. The kit of claim 1 , further comprising an applicator for contacting the first composition with the second composition comprising the solution.

7. The kit of claim 4 , further comprising an applicator for applying the second composition comprising the solution to the first composition or for applying the implant to a site within or on a body tissue.

8. A kit for use in forming an implant, the kit comprising:

a first composition including a calcium ceramic granule having a specific surface area greater than 30 m2/g, a pH less than 7, and an interconnected network of micropores defining at least one surface on an interior of the granule, wherein said micropores prevent multinucleated osteoclasts from penetrating into the interior of the granules; and

a second composition comprising a solution comprising a buffering agent having a pKa between 2.3 and 4.5, the solution having a pH of less than 4.0; and

a third composition comprising an osteoinductive protein wherein the first composition, second composition and third composition are maintained separately.

9. The kit of claim 8 , wherein the osteoinductive protein is lyophilized.

10. The kit of claim 8 , further comprising an applicator for placing the implant at a site within or on a body tissue or for contacting the composition or the osteoinductive protein with the solution.

11. The kit of claim 10 , wherein the applicator is a syringe.

Assignments (4)
SECURITY INTEREST Recorded Aug 1, 2025
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071904/0465 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 071909/0861 →
SECURITY INTEREST Recorded Dec 13, 2019
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051272/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2019
From: VANDERPLOEG, ERIC; SEEHERMAN, HOWARD; WILSON, CHRISTOPHER C.; WOZNEY, JOHN; BROWN, CHRISTOPHER T.; KAMBOURIS, JOHN A.
To: BIOVENTUS, LLC
Reel/Frame 047880/0769 →
Continuity (5)
Division 14983008 · Dec 29, 2015
Provisional Application 62182301 · Jun 19, 2015
Provisional Application 62144276 · Apr 7, 2015
Provisional Application 62097363 · Dec 29, 2014
Related Publication 20190070256A1 · Mar 7, 2019